{"disease":{"id":"condyloma-acuminatum","name":"Condyloma acuminatum","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":6,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"interferon-alfa-2b","indication_name":"Condyloma acuminatum","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Intron A","generic_name":"INTERFERON ALFA-2B","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"","drug_class":"Interferon alpha","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"cianidanol","indication_name":"Condyloma acuminatum","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Catechin","generic_name":"CIANIDANOL","company_name":"","drug_phase":"marketed","molecular_target":"Carbonic anhydrase 7","drug_class":"","quality_score":20,"revenue":null,"mechanism":""},{"drug_id":"benzoin","indication_name":"Condyloma acuminatum","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Desyl Alcohol","generic_name":"benzoin","company_name":"","drug_phase":"marketed","molecular_target":"Cocaine esterase","drug_class":"benzoin","quality_score":20,"revenue":null,"mechanism":""},{"drug_id":"podophyllotoxin","indication_name":"Condyloma acuminatum","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Condylox","generic_name":"podophyllotoxin","company_name":"Actavis Labs Ut Inc","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"podophyllotoxin","quality_score":60,"revenue":null,"mechanism":"Condylox works by disrupting cell division and preventing the growth of abnormal cells."},{"drug_id":"trichloroacetic-acid","indication_name":"Condyloma acuminatum","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Trichloracetic Acid","generic_name":"TRICHLOROACETIC ACID","company_name":"","drug_phase":"discontinued","molecular_target":"","drug_class":"trichloroacetic acid","quality_score":null,"revenue":null,"mechanism":"Trichloroacetic acid works by directly destroying infected cells on the skin's surface."},{"drug_id":"imiquimod","indication_name":"Condyloma acuminatum","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aldara","generic_name":"IMIQUIMOD","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"7,8-dihydro-8-oxoguanine triphosphatase","drug_class":"imiquimod","quality_score":75,"revenue":null,"mechanism":"Aldara works by activating the immune system to recognize and attack abnormal cells."}],"pipeline":[],"offLabel":[],"totalMarketed":6,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}